{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T21:18:42Z","timestamp":1774300722696,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T00:00:00Z","timestamp":1409097600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s12035-014-8861-z","type":"journal-article","created":{"date-parts":[[2014,8,26]],"date-time":"2014-08-26T03:26:58Z","timestamp":1409023618000},"page":"318-329","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Rapid Regulation of Depression-Associated Genes in a New Mouse Model Mimicking Interferon-\u03b1-Related Depression in Hepatitis C Virus Infection"],"prefix":"10.1007","volume":"52","author":[{"given":"Carolina","family":"Hoyo-Becerra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zijian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinghong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britta","family":"Kaltwasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Gerken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk M.","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joerg F.","family":"Schlaak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,27]]},"reference":[{"key":"8861_CR1","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/hep.1840360704","volume":"36","author":"JH Hoofnagle","year":"2002","unstructured":"Hoofnagle JH (2002) Course and outcome of hepatitis C. Hepatology 36:S21\u2013S29","journal-title":"Hepatology"},{"key":"8861_CR2","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","volume":"347","author":"MW Fried","year":"2002","unstructured":"Fried MW, Shiffman ML, Reddy KR et al (2002) Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347:975\u2013982","journal-title":"N Engl J Med"},{"key":"8861_CR3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11920-007-0028-4","volume":"9","author":"B Keefe","year":"2007","unstructured":"Keefe B (2007) Interferon-induced depression in hepatitis C: an update. Curr Psychiatry Rep 9:255\u2013261","journal-title":"Curr Psychiatry Rep"},{"key":"8861_CR4","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1177\/135965350601100814","volume":"11","author":"ML Yu","year":"2006","unstructured":"Yu ML, Dai CY, Lee LP et al (2006) Outcome of chronic hepatitis C patients who required early termination of pegylated interferon-alpha plus ribavirin combination therapy. Antivir Ther 11:1015\u20131019","journal-title":"Antivir Ther"},{"key":"8861_CR5","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.jhep.2012.07.037","volume":"57","author":"M Schaefer","year":"2012","unstructured":"Schaefer M, Capuron L, Friebe A et al (2012) Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement. J Hepatol 57:1379\u20131390","journal-title":"J Hepatol"},{"issue":"Suppl B","key":"8861_CR6","first-page":"28","volume":"60","author":"R Guan","year":"2005","unstructured":"Guan R (2005) Treatment of chronic hepatitis B infection using interferon. Med J Malaysia 60(Suppl B):28\u201333","journal-title":"Med J Malaysia"},{"key":"8861_CR7","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.2174\/092986710793176393","volume":"17","author":"S Pasquali","year":"2010","unstructured":"Pasquali S, Mocellin S (2010) The anticancer face of interferon alpha (IFN-alpha): from biology to clinical results, with a focus on melanoma. Curr Med Chem 17:3327\u20133336","journal-title":"Curr Med Chem"},{"key":"8861_CR8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4088\/JCP.v66n0106","volume":"66","author":"CL Raison","year":"2005","unstructured":"Raison CL, Borisov AS, Broadwell SD, Capuron L, Woolwine BJ, Jacobson IM, Nemeroff CB, Miller AH (2005) Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction. J Clin Psychiatry 66:41\u201348","journal-title":"J Clin Psychiatry"},{"key":"8861_CR9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/hep.510240102","volume":"24","author":"TV Cacciarelli","year":"1996","unstructured":"Cacciarelli TV, Martinez OM, Gish RG, Villanueva JC, Krams SM (1996) Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa. Hepatology 24:6\u20139","journal-title":"Hepatology"},{"key":"8861_CR10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jpsychores.2006.09.007","volume":"62","author":"MC Wichers","year":"2007","unstructured":"Wichers MC, Kenis G, Koek GH, Robaeys G, Nicolson NA, Maes M (2007) Interferon-alpha-induced depressive symptoms are related to changes in the cytokine network but not to cortisol. J Psychosom Res 62:207\u2013214","journal-title":"J Psychosom Res"},{"key":"8861_CR11","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctot KL (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67:446\u2013457","journal-title":"Biol Psychiatry"},{"key":"8861_CR12","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/mp.2012.125","volume":"18","author":"CD Rethorst","year":"2013","unstructured":"Rethorst CD, Toups MS, Greer TL, Nakonezny PA, Carmody TJ, Grannemann BD, Huebinger RM, Barber RC, Trivedi MH (2013) Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder. Mol Psychiatry 18:1119\u20131124","journal-title":"Mol Psychiatry"},{"key":"8861_CR13","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","volume":"65","author":"AH Miller","year":"2009","unstructured":"Miller AH, Maletic V, Raison CL (2009) Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65:732\u2013741","journal-title":"Biol Psychiatry"},{"key":"8861_CR14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","volume":"27","author":"CL Raison","year":"2006","unstructured":"Raison CL, Capuron L, Miller AH (2006) Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 27:24\u201331","journal-title":"Trends Immunol"},{"key":"8861_CR15","doi-asserted-by":"crossref","first-page":"236148","DOI":"10.1155\/2012\/236148","volume":"2012","author":"S Monaco","year":"2012","unstructured":"Monaco S, Ferrari S, Gajofatto A, Zanusso G, Mariotto S (2012) HCV-related nervous system disorders. Clin Dev Immunol 2012:236148","journal-title":"Clin Dev Immunol"},{"key":"8861_CR16","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1136\/gut.2009.199356","volume":"59","author":"J Wilkinson","year":"2010","unstructured":"Wilkinson J, Radkowski M, Eschbacher JM, Laskus T (2010) Activation of brain macrophages\/microglia cells in hepatitis C infection. Gut 59:1394\u20131400","journal-title":"Gut"},{"key":"8861_CR17","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/jnen\/61.11.1013","volume":"61","author":"M Bsibsi","year":"2002","unstructured":"Bsibsi M, Ravid R, Gveric D, van Noort JM (2002) Broad expression of toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol 61:1013\u20131021","journal-title":"J Neuropathol Exp Neurol"},{"key":"8861_CR18","doi-asserted-by":"crossref","first-page":"13033","DOI":"10.1523\/JNEUROSCI.4290-06.2007","volume":"27","author":"JS Cameron","year":"2007","unstructured":"Cameron JS, Alexopoulou L, Sloane JA et al (2007) Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals. J Neurosci 27:13033\u201313041","journal-title":"J Neurosci"},{"key":"8861_CR19","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.4049\/jimmunol.175.7.4320","volume":"175","author":"CS Jack","year":"2005","unstructured":"Jack CS, Arbour N, Manusow J, Montgrain V, Blain M, McCrea E, Shapiro A, Antel JP (2005) TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol 175:4320\u20134330","journal-title":"J Immunol"},{"key":"8861_CR20","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.4049\/jimmunol.173.6.3916","volume":"173","author":"JK Olson","year":"2004","unstructured":"Olson JK, Miller SD (2004) Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 173:3916\u20133924","journal-title":"J Immunol"},{"key":"8861_CR21","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","volume":"413","author":"L Alexopoulou","year":"2001","unstructured":"Alexopoulou L, Holt AC, Medzhitov R, Flavell RA (2001) Recognition of double-stranded RNA and activation of NF-kappaB by toll-like receptor 3. Nature 413:732\u2013738","journal-title":"Nature"},{"key":"8861_CR22","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/glia.20117","volume":"49","author":"PA Carpentier","year":"2005","unstructured":"Carpentier PA, Begolka WS, Olson JK, Elhofy A, Karpus WJ, Miller SD (2005) Differential activation of astrocytes by innate and adaptive immune stimuli. Glia 49:360\u2013374","journal-title":"Glia"},{"key":"8861_CR23","doi-asserted-by":"crossref","first-page":"e83149","DOI":"10.1371\/journal.pone.0083149","volume":"8","author":"C Hoyo-Becerra","year":"2013","unstructured":"Hoyo-Becerra C, Huebener A, Trippler M et al (2013) Concomitant interferon alpha stimulation and TLR3 activation induces neuronal expression of depression-related genes that are elevated in the brain of suicidal persons. PLoS One 8:e83149","journal-title":"PLoS One"},{"key":"8861_CR24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1385\/JMN:29:3:185","volume":"29","author":"M Lafon","year":"2006","unstructured":"Lafon M, Megret F, Lafage M, Prehaud C (2006) The innate immune facet of brain: human neurons express TLR-3 and sense viral dsRNA. J Mol Neurosci 29:185\u2013194","journal-title":"J Mol Neurosci"},{"key":"8861_CR25","doi-asserted-by":"crossref","first-page":"e38668","DOI":"10.1371\/journal.pone.0038668","volume":"7","author":"JF Schlaak","year":"2012","unstructured":"Schlaak JF, Trippler M, Hoyo-Becerra C, Erim Y, Kis B, Wang B, Scherbaum N, Gerken G (2012) Selective hyper-responsiveness of the interferon system in major depressive disorders and depression induced by interferon therapy. PLoS One 7:e38668","journal-title":"PLoS One"},{"key":"8861_CR26","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1126\/scisignal.2003579","volume":"5","author":"H Anisman","year":"2012","unstructured":"Anisman H, Hayley S (2012) Inflammatory factors contribute to depression and its comorbid conditions. Sci Signal 5:e45","journal-title":"Sci Signal"},{"key":"8861_CR27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bbi.2012.07.023","volume":"31","author":"S Hayley","year":"2013","unstructured":"Hayley S, Scharf J, Anisman H (2013) Central administration of murine interferon-alpha induces depressive-like behavioral, brain cytokine and neurochemical alterations in mice: a mini-review and original experiments. Brain Behav Immun 31:115\u2013127","journal-title":"Brain Behav Immun"},{"key":"8861_CR28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.psychres.2009.10.012","volume":"185","author":"M Kosel","year":"2011","unstructured":"Kosel M, Bilkei-Gorzo A, Zawatzky R, Zimmer A, Schlaepfer TE (2011) Pegylated human interferon alpha 2a does not induce depression-associated changes in mice. Psychiatry Res 185:243\u2013247","journal-title":"Psychiatry Res"},{"key":"8861_CR29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neulet.2010.05.082","volume":"479","author":"H Zhang","year":"2010","unstructured":"Zhang H, Tian Z, Wang J (2010) Behavioral evaluation of transgenic mice with CNS expression of IFN-alpha by elevated plus-maze and Porsolt swim test. Neurosci Lett 479:287\u2013291","journal-title":"Neurosci Lett"},{"key":"8861_CR30","doi-asserted-by":"crossref","first-page":"15625","DOI":"10.1073\/pnas.1005807107","volume":"107","author":"E Okun","year":"2010","unstructured":"Okun E, Griffioen K, Barak B et al (2010) Toll-like receptor 3 inhibits memory retention and constrains adult hippocampal neurogenesis. Proc Natl Acad Sci U S A 107:15625\u201315630","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8861_CR31","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","volume":"85","author":"L Steru","year":"1985","unstructured":"Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berlin) 85:367\u2013370","journal-title":"Psychopharmacology (Berlin)"},{"key":"8861_CR32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0149-7634(94)00050-B","volume":"19","author":"F Borsini","year":"1995","unstructured":"Borsini F (1995) Role of the serotonergic system in the forced swimming test. Neurosci Biobehav Rev 19:377\u2013395","journal-title":"Neurosci Biobehav Rev"},{"key":"8861_CR33","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00006842-200105000-00007","volume":"63","author":"L Capuron","year":"2001","unstructured":"Capuron L, Ravaud A, Dantzer R (2001) Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-alpha treatments in cancer patients. Psychosom Med 63:376\u2013386","journal-title":"Psychosom Med"},{"key":"8861_CR34","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.bbi.2011.02.015","volume":"25","author":"JC Felger","year":"2011","unstructured":"Felger JC, Alagbe O, Pace TW, Woolwine BJ, Hu F, Raison CL, Miller AH (2011) Early activation of p38 mitogen activated protein kinase is associated with interferon-alpha-induced depression and fatigue. Brain Behav Immun 25:1094\u20131098","journal-title":"Brain Behav Immun"},{"key":"8861_CR35","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/01.cji.0000211346.19330.c9","volume":"30","author":"A Friebe","year":"2007","unstructured":"Friebe A, Schwarz MJ, Schmid-Wendtner M, Volkenandt M, Schmidt F, Horn M, Janssen G, Schaefer M (2007) Pretreatment levels of sTNF-R1 and sIL-6R are associated with a higher vulnerability for IFN-alpha-induced depressive symptoms in patients with malignant melanoma. J Immunother 30:333\u2013337","journal-title":"J Immunother"},{"key":"8861_CR36","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bbr.2007.05.005","volume":"182","author":"B Fahey","year":"2007","unstructured":"Fahey B, Hickey B, Kelleher D, O\u2019Dwyer AM, O\u2019Mara SM (2007) The widely-used anti-viral drug interferon-alpha induces depressive- and anxiogenic-like effects in healthy rats. Behav Brain Res 182:80\u201387","journal-title":"Behav Brain Res"},{"key":"8861_CR37","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.neulet.2012.02.087","volume":"514","author":"F Ping","year":"2012","unstructured":"Ping F, Shang J, Zhou J, Zhang H, Zhang L (2012) 5-HT(1A) receptor and apoptosis contribute to interferon-alpha-induced \u201cdepressive-like\u201d behavior in mice. Neurosci Lett 514:173\u2013178","journal-title":"Neurosci Lett"},{"key":"8861_CR38","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1086\/526519","volume":"197","author":"SL Fishman","year":"2008","unstructured":"Fishman SL, Murray JM, Eng FJ, Walewski JL, Morgello S, Branch AD (2008) Molecular and bioinformatic evidence of hepatitis C virus evolution in brain. J Infect Dis 197:597\u2013607","journal-title":"J Infect Dis"},{"key":"8861_CR39","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1128\/JVI.01890-08","volume":"83","author":"J Wilkinson","year":"2009","unstructured":"Wilkinson J, Radkowski M, Laskus T (2009) Hepatitis C virus neuroinvasion: identification of infected cells. J Virol 83:1312\u20131319","journal-title":"J Virol"},{"key":"8861_CR40","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.biopsych.2007.05.026","volume":"62","author":"JC Felger","year":"2007","unstructured":"Felger JC, Alagbe O, Hu F et al (2007) Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression. Biol Psychiatry 62:1324\u20131333","journal-title":"Biol Psychiatry"},{"key":"8861_CR41","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000201718","volume":"58","author":"AS Orsal","year":"2008","unstructured":"Orsal AS, Blois SM, Bermpohl D, Schaefer M, Coquery N (2008) Administration of interferon-alpha in mice provokes peripheral and central modulation of immune cells, accompanied by behavioral effects. Neuropsychobiology 58:211\u2013222","journal-title":"Neuropsychobiology"},{"key":"8861_CR42","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.neubiorev.2005.03.023","volume":"29","author":"AJ Dunn","year":"2005","unstructured":"Dunn AJ, Swiergiel AH, de Beaurepaire R (2005) Cytokines as mediators of depression: what can we learn from animal studies? Neurosci Biobehav Rev 29:891\u2013909","journal-title":"Neurosci Biobehav Rev"},{"key":"8861_CR43","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1192\/bjp.bp.109.076430","volume":"197","author":"JA Pasco","year":"2010","unstructured":"Pasco JA, Nicholson GC, Williams LJ, Jacka FN, Henry MJ, Kotowicz MA, Schneider HG, Leonard BE, Berk M (2010) Association of high-sensitivity C-reactive protein with de novo major depression. Br J Psychiatry 197:372\u2013377","journal-title":"Br J Psychiatry"},{"key":"8861_CR44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11011-008-9130-5","volume":"24","author":"K Weissenborn","year":"2009","unstructured":"Weissenborn K, Tryc AB, Heeren M, Worthmann H, Pflugrad H, Berding G, Bokemeyer M, Tillmann HL, Goldbecker A (2009) Hepatitis C virus infection and the brain. Metab Brain Dis 24:197\u2013210","journal-title":"Metab Brain Dis"},{"key":"8861_CR45","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1038\/npp.2011.132","volume":"36","author":"J Hannestad","year":"2011","unstructured":"Hannestad J, DellaGioia N, Bloch M (2011) The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 36:2452\u20132459","journal-title":"Neuropsychopharmacology"},{"key":"8861_CR46","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.bbi.2012.06.001","volume":"26","author":"SA Hiles","year":"2012","unstructured":"Hiles SA, Baker AL, de Malmanche T, Attia J (2012) A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: exploring the causes of heterogeneity. Brain Behav Immun 26:1180\u20131188","journal-title":"Brain Behav Immun"},{"key":"8861_CR47","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","volume":"71","author":"MB Howren","year":"2009","unstructured":"Howren MB, Lamkin DM, Suls J (2009) Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 71:171\u2013186","journal-title":"Psychosom Med"},{"key":"8861_CR48","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000026615","volume":"40","author":"J Levine","year":"1999","unstructured":"Levine J, Barak Y, Chengappa KN, Rapoport A, Rebey M, Barak V (1999) Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology 40:171\u2013176","journal-title":"Neuropsychobiology"},{"key":"8861_CR49","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1007\/s11064-011-0547-6","volume":"36","author":"K Osuka","year":"2011","unstructured":"Osuka K, Watanabe Y, Usuda N, Atsuzawa K, Yasuda M, Aoshima C, Wakabayashi T, Takayasu M (2011) Activation of STAT1 in neurons following spinal cord injury in mice. Neurochem Res 36:2236\u20132243","journal-title":"Neurochem Res"},{"key":"8861_CR50","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/j.1471-4159.2010.07046.x","volume":"115","author":"S Dedoni","year":"2010","unstructured":"Dedoni S, Olianas MC, Onali P (2010) Interferon-beta induces apoptosis in human SH-SY5Y neuroblastoma cells through activation of JAK-STAT signaling and down-regulation of PI3K\/Akt pathway. J Neurochem 115:1421\u20131433","journal-title":"J Neurochem"},{"key":"8861_CR51","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s000180050391","volume":"55","author":"C Schindler","year":"1999","unstructured":"Schindler C, Brutsaert S (1999) Interferons as a paradigm for cytokine signal transduction. Cell Mol Life Sci 55:1509\u20131522","journal-title":"Cell Mol Life Sci"},{"key":"8861_CR52","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbi.2008.08.006","volume":"23","author":"AH Miller","year":"2009","unstructured":"Miller AH (2009) Norman cousins lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface. Brain Behav Immun 23:149\u2013158","journal-title":"Brain Behav Immun"},{"key":"8861_CR53","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/j.1582-4934.2010.01146.x","volume":"15","author":"M Hammon","year":"2011","unstructured":"Hammon M, Herrmann M, Bleiziffer O et al (2011) Role of guanylate binding protein-1 in vascular defects associated with chronic inflammatory diseases. J Cell Mol Med 15:1582\u20131592","journal-title":"J Cell Mol Med"},{"key":"8861_CR54","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1128\/JVI.02167-08","volume":"83","author":"E Larrea","year":"2009","unstructured":"Larrea E, Aldabe R, Gonzalez I, Segura V, Sarobe P, Echeverria I, Prieto J (2009) Oncostatin M enhances the antiviral effects of type I interferon and activates immunostimulatory functions in liver epithelial cells. J Virol 83:3298\u20133311","journal-title":"J Virol"},{"key":"8861_CR55","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.4049\/jimmunol.130.3.1047","volume":"130","author":"C Huber","year":"1983","unstructured":"Huber C, Fuchs D, Hausen A, Margreiter R, Reibnegger G, Spielberger M, Wachter H (1983) Pteridines as a new marker to detect human T cells activated by allogeneic or modified self major histocompatibility complex (MHC) determinants. J Immunol 130:1047\u20131050","journal-title":"J Immunol"},{"key":"8861_CR56","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1084\/jem.160.1.310","volume":"160","author":"C Huber","year":"1984","unstructured":"Huber C, Batchelor JR, Fuchs D et al (1984) Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med 160:310\u2013316","journal-title":"J Exp Med"},{"key":"8861_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2014.06.200","author":"C Hoyo-Becerra","year":"2014","unstructured":"Hoyo-Becerra C, Schlaak JF, Hermann DM (2014) Insights from interferon-alpha-related depression for the pathogenesis of depression associated with inflammation. Brain Behav Immun. doi: 10.1016\/j.bbi.2014.06.200","journal-title":"Brain Behav Immun"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-014-8861-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-014-8861-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-014-8861-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-014-8861-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T06:49:56Z","timestamp":1689490196000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-014-8861-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,27]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["8861"],"URL":"https:\/\/doi.org\/10.1007\/s12035-014-8861-z","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,27]]}}}